Houston Methodist DeBakey Heart and Vascular Center
J

Debate: CCTA and FFR-CT Should Be the First Choice in the Assessment of Suspected CAD: Pro

By Houston Methodist DeBakey Heart and Vascular Center FEATURING Jonathon Leipsic
By Houston Methodist DeBakey Heart and Vascular Center FEATURING Jonathon Leipsic
0 views
January 5, 2022
Comments 1
Login to view comments. Click here to Login

Featured Video

26:13
Lilly Diabetes

A Journey through Five Phase 3 Clinical Trials for a T2D Incretin Me…

Feat. B. Hirsch

Featured Video

46:20
Lilly Diabetes

A Journey Through Clinical Efficacy and Safety Data Comparing Two In…

Feat. S. Shadid

Recommended

AUTOPLAY
25:52
Society for Cardiovascular Angiography & Interventions (SCAI)

CVD Risk Assessment: Will CCTA with FFRCT and Plaque Analysis Change…

Feat. G. Fandetti, S. Rinehart
08:23
Society for Cardiovascular Angiography & Interventions (SCAI)

Case-Study: FFRCT & Disruptive Technology at My Facility

Feat. M. Rinaldi
16:57
William White

Ambulatory Blood Pressure Monitoring

20:48
Michael Gallagher

Cardiac CT in 2023: From Anatomy to Physiology to Plaque Burden and …

26:11
13th Orange County Symposium for Cardiovascular Disease Prevention

Update on Calcium Screening and CTA: Role in Prevention

Feat. M. Budoff
42:28
Scripps Health

CT Coronary Calcium Scoring, Hard Plaque and Soft Plaque Visualizati…

Feat. M. Budoff
59:01
The North American Thrombosis Forum (NATF)

Recent Cholesterol Guidelines and Integration into Clinical Practice

Feat. J. Plutzky, L. Braun, J. Ross
18:43
Canadian Collaborative Research Network

Lp(a): When to Measure it and What to Do About it

Feat. M. O'Donoghue
13:58
Matthew Budoff

Coronary CTA for Assessing CAD - Are We There Yet?

53:05
Joel Gorfinkel

The History of Invasive Cardiac Procedures

19:16
The Texas Heart Institute

Role of Coronary Calcification and Risk Stratification

Feat. E. Hernandez
08:44
AHA 2022 Conference Coverage

AHA 2022: Cardiovascular Benefit of Lowering LDL Cholesterol Below 4…

Feat. N. Marston
14:50
AHA 2022 Conference Coverage

AHA 2022: Long-Term Efficacy and Safety of Inclisiran in Patients Wi…

Feat. K. Ray
24:02
Complex Coronary Cases

Updated Lipid Guidelines and Therapy

Feat. I. Fergus
19:24
National Lipid Association

Do Triglycerides Cause Heart Disease?

Feat. I. Goldberg
34:20
Cedars Sinai

Cardiology’s Biggest Controversy: The Lumen or the Wall - the Curiou…

Feat. J. Forrester
21:34
Canadian Collaborative Research Network

Should Colchicine Become Standard Therapy for CAD?

Feat. P. Ridker
45:45
Houston Methodist DeBakey Heart and Vascular Center

Directions of Cardiology in the Next Decade: 2022-2032

Feat. E. Braunwald
21:46
Complex Interventional Cardiovascular Therapy (CICT) 2014

What is the Gold Standard for Non-Invasive Cardiac Stress Testing

Feat. M. Bell
31:02
Scripps Health

How Do I Reverse Coronary Plaque?

Feat. C. J. Suhar